Current Value of Holding

$703 Thousand

Shares

87.4 Thousand

% of Portfolio

0.01%

Average Buy Price

$14.6

Avg closing price
Price range

24 Paul Tudor Jones II Neogenomics Trades

Paul Tudor Jones II acquired 87.4 Thousand Neogenomics shares worth $703 Thousand. That's 0.01% of their equity portfolio (1019th largest holding). The first Neogenomics trade was made in Q2 2016. Since then Paul Tudor Jones II bought shares fifteen more times and sold shares on eight occasions. The investor's estimated purchase price is $1.28 Million, resulting in a loss of 45%.

Avg closing price
Price range
Sold 59.8% shares (-130 Thousand shares) Q4 2024
Avg closing price $15.60
Price range $13.00 - $18.43
Increased shares by 45.1% (+67.5 Thousand shares) Q3 2024
Avg closing price $15.63
Price range $13.40 - $17.73
New holding (+150 Thousand shares) Q2 2024
Avg closing price $14.18
Price range $13.01 - $15.77
Sold -28.8 Thousand shares Q1 2024
Avg closing price $15.44
Price range $14.06 - $16.79
New holding (+28.8 Thousand shares) Q4 2023
Avg closing price $16.36
Price range $11.66 - $20.73
Sold -165 Thousand shares Q3 2023
Avg closing price $14.87
Price range $12.15 - $17.85
Increased shares by 24.8% (+32.9 Thousand shares) Q2 2023
Avg closing price $16.48
Price range $14.10 - $19.83
Increased shares by 16.0% (+18.3 Thousand shares) Q1 2023
Avg closing price $14.25
Price range $9.09 - $19.45
Increased shares by 106.0% (+58.8 Thousand shares) Q4 2022
Avg closing price $9.32
Price range $6.45 - $12.07
New holding (+55.4 Thousand shares) Q3 2022
Avg closing price $9.93
Price range $7.86 - $12.91
Sold -24.8 Thousand shares Q2 2022
Avg closing price $9.55
Price range $7.06 - $13.97
New holding (+24.8 Thousand shares) Q1 2022
Avg closing price $21.04
Price range $12.15 - $35.28
Sold -11 Thousand shares Q2 2021
Avg closing price $44.31
Price range $36.62 - $51.69
New holding (+11 Thousand shares) Q1 2021
Avg closing price $52.06
Price range $41.56 - $59.88
Sold -77.9 Thousand shares Q1 2019
Avg closing price $17.38
Price range $12.14 - $20.46
Increased shares by 73.1% (+32.9 Thousand shares) Q4 2018
Avg closing price $14.90
Price range $11.24 - $18.50
Increased shares by 8.4% (+3.47 Thousand shares) Q3 2018
Avg closing price $13.82
Price range $12.50 - $15.38
Increased shares by 153.6% (+25.2 Thousand shares) Q2 2018
Avg closing price $11.00
Price range $7.99 - $14.05
New holding (+16.4 Thousand shares) Q1 2018
Avg closing price $8.10
Price range $7.23 - $8.76
Sold -45.6 Thousand shares Q2 2017
Avg closing price $7.94
Price range $7.24 - $8.97

News about Neogenomics Inc. and Paul Tudor Jones II

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!